Teligene Us
Clinical trials sponsored by Teligene Us, explained in plain language.
-
New hope for rare cancers: targeted drug TL118 enters phase 2 trial
Disease control Recruiting nowThis study tests an experimental drug called TL118 in adults with advanced solid tumors that have a specific genetic change (NTRK gene fusion). The goal is to see if TL118 can shrink tumors or stop them from growing. About 60 participants will receive the drug, and researchers wi…
Phase: PHASE2 • Sponsor: Teligene US • Aim: Disease control
Last updated May 26, 2026 06:20 UTC
-
New pill shows promise for hard-to-treat lung cancer
Disease control Recruiting nowThis study tests an experimental pill, sutetinib, in people with advanced lung cancer that has certain uncommon gene changes (EGFR mutations). About 99 adults will take the drug to see if it shrinks tumors and how safe it is. The goal is to find a better treatment option for this…
Phase: PHASE2 • Sponsor: Teligene US • Aim: Disease control
Last updated May 26, 2026 06:15 UTC
-
New pill shows promise for rare lung cancer mutations in early trial
Disease control Recruiting nowThis study tests an experimental drug called sutetinib maleate in people with advanced non-small cell lung cancer that has uncommon EGFR mutations. The goal is to see if the drug can shrink tumors or slow cancer growth. About 66 adults will take the capsule and be monitored for r…
Phase: PHASE2 • Sponsor: Teligene US • Aim: Disease control
Last updated May 19, 2026 11:48 UTC